Polyamide wax

Repeated dose toxicity: oral

Some information in this page has been claimed confidential.

Administrative data

Endpoint:

short-term repeated dose toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2000

Report Date:

2000

Materials and methods

Test guideline

Qualifier:

according to

Guideline:

OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity in Rodents)

Version / remarks:

1995

Deviations:

no

Limit test:

no

Test material

Reference

Name:

Unnamed

Type:

Constituent

Test animals

Species:

rat

Strain:

other: CD® (SD) IGS BR

Sex:

male/female

Administration / exposure

Route of administration:

oral: gavage

Results and discussion

Results of examinations

Details on results:

CLINICAL SIGNS AND MORTALITY
There were no deaths and no clinical signs related to the treatment with the test material.

BODY WEIGHT AND WEIGHT GAIN
Bodyweight gain was considered to be unaffected by treatment.

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
Food consumption was considered to be unaffected by treatment.

FOOD EFFICIENCY
Food conversion efficiency was considered to be unaffected by treatment.

HAEMATOLOGY
There were no haematologival changes which were considered to be related to treatment.
A few inter-group differences attained statistical significance but there were minor, seen in one sex only and were considered to have arisen by chance.

CLINICAL CHEMISTRY
No clinical chemistry changes which were considered to be related with treatment.

NEUROBEHAVIOUR
There were no inter-group differences in arena observations that were considered to be associated with treatment.
Landing footsplay and grip strength measurements showed some inter-group variation during week 4 of treatment and some differences achieved statistical significance. There were, however, no consistent trends and many of the differences were apparent before commencement of treatment, an association with treatment was therefore discounted.
Motor activity was unaffected by treatment.

ORGAN WEIGHTS
Organ weights were unaffected by treatment.

GROSS PATHOLOGY
Macroscopic examination of animals killed on completion of the treatment period did not reveal any treatment-related findings.

HISTOPATHOLOGY: NON-NEOPLASTIC
There were no microscopic findings which were attributable to treatment with the test material. All microscopic findings were considered to be incidental and of no toxicological importance.

Effect levels

Dose descriptor:

NOEL

Effect level:

1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Sex:

male/female

Remarks on result:

not determinable due to absence of adverse toxic effects

Target system / organ toxicity

Critical effects observed:

no